Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)-Reference-Cited by-同舟云学术

Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)

Published:2023-05 Issue:5 Volume:78 Page:914-925
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Harrison Stephen A.,Thang Carole,Bolze Sébastien,Dewitt Sheila^ORCID,Hallakou-Bozec Sophie^ORCID,Dubourg Julie^ORCID,Bedossa Pierre,Cusi Kenneth,Ratziu Vlad^ORCID,Grouin Jean-Marie,Moller David E.^ORCID,Fouqueray Pascale

Publisher

Elsevier BV

Subject

Hepatology

Reference64 articles.

1. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022

2. Burden of non-alcoholic fatty liver disease in Asia, the middle east and north Africa: data from global burden of disease 2009-2019;Golabi;J Hepatol,2021

3. Non-alcoholic fatty liver disease;Powell;Lancet,2021

4. From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options;Gastaldelli;JHEP Rep,2019

5. Breakthroughs in therapies for NASH and remaining challenges;Ratziu;J Hepatol,2022

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?;Digestive and Liver Disease;2024-09

2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

3. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08

4. Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease;Journal of Clinical and Translational Hepatology;2024-07-31

5. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07